Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis
Sign Up to like & getrecommendations! Published in 2022 at "Korean Journal of Ophthalmology : KJO"
DOI: 10.3341/kjo.2022.0061
Abstract: Purpose Netarsudil is a Rho kinase inhibitor and the first new class of clinically useful ocular hypotensive agents. In this study, we conducted a systematic literature review and meta-analysis to summarize and synthesize the available… read more here.
Keywords: netarsudil latanoprost; latanoprost monotherapy; therapy; fdc therapy ... See more keywords